Recall Register

Food, drugs, devices › Haemonetics Corporation

Device recall: Haemonetics OrthoPAT System-Integrated Set. Product Code: 1150H-00 OrthoPAT orthopedic perioperative autotransfusion sys

FDA enforcement event 80740 · Class II · initiated 13 Jul 2018 · status Terminated · terminated 16 Jun 2020

DeviceVoluntary: Firm initiated2 product recordsBraintree, MA

Haemonetics Corporation (Braintree, MA) initiated this device recall on 13 Jul 2018; FDA lists 2 product records under event 80740, classified Class II.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 92% of the 1,074 device enforcement events initiated in 2018 carry the same class.

Status: Terminated, terminated 16 Jun 2020. Initiation: voluntary: firm initiated. Haemonetics Corporation has 8 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Haemonetics Corporation, Braintree, MA.

Reason for recall

"OrthoPAT¿ reservoirs are missing the cannula inside the reservoirs. The absence of this cannula prevents the emptying of blood from the reservoirs. The inability to empty the reservoir means that the collected blood cannot be processed."

Distribution

"US Nationwide Distribution"

Product records

Recall numberProductQuantityClassStatusReport date
Z-2950-2018Haemonetics OrthoPAT System-Integrated Set. Product Code: 1150H-00 OrthoPAT orthopedic perioperative autotransfusion system indicated for use to salvage RBCs from blood lost intraoperatively and postoperatively during surgical procedures432 unitsClass IITerminated5 Sep 2018
Z-2951-2018Haemonetics¿ OrthoPAT¿ System-OPAT QuickConnect Reservoirs. Product Code: OPT-R-1000 The OrthoPAT orthopedic perioperative autotransfusion system indicated for use to salvage RBCs from blood lost intraoperatively and postoperatively during surgical procedures348 unitsClass IITerminated5 Sep 2018

Context

92%of 2018 device events are Class II1,074 events that year
2product records in this eventfirm median: 1
8events on this register for the firm

Other enforcement events for Haemonetics Corporation

InitiatedProduct (first record)TypeClassRecords
26 Apr 2022TEG 5000 Functional Fibrinogen Reagent, Item No. 07-034DeviceClass II1
19 Apr 2022Product Name: TEG5000 Analyzer (07-022, 07-033) with TEG Analytical Software (07-030, 07-031) and TEG Platelet Mapping ADeviceClass II1
19 Feb 2020TEG Manager software versions used in conjunction with TEG 5000 are 1.1.0, 3.0.0, 4.0.0, 4.1.0 and 4.1.1. Intended: For DeviceClass II1
21 Oct 2019CS5/5+ Fastpacks, 225 mL, 150¿ Res Autotransfusion Device - Product Usage: its related accessory components are intendedDeviceClass II22
2 Aug 2017Cell Saver 5/5+ Bowl Set, 70ml, Product ID: 0291E-00, 0291A-00 Indications for Use: The Haemonetics Cell Saver 5/5+ SystDeviceClass II2
26 Jan 2015Haemonetics TEG Hemostasis System Level II Control, Catalog number: 8002. Level II Control is a biological control for uDeviceClass II1
20 Jun 2013TEG 5000 Thromboelastograph Coagulation Analyzer Product Usage: Multipurpose System for In Vitro Coagulation StudiesDeviceClass II1

All 8 events for Haemonetics Corporation

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "OrthoPAT¿ reservoirs are missing the cannula inside the reservoirs. The absence of this cannula prevents the emptying of blood from the reservoirs. The inability to empty the reservoir means that the collected blood cannot be processed."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "US Nationwide Distribution"

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 16 Jun 2020. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.